Shattuck Labs, Inc. financial data

Symbol
STTK on Nasdaq
Industry
Pharmaceutical Preparations
Location
500 W. 5 Th Street, Austin, Texas
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 2, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 991 % +8.13%
Debt-to-equity 12.7 % -5.14%
Return On Equity -64.9 % -24.9%
Return On Assets -57.5 % -25.6%
Operating Margin -3.33 K % +76.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 47.6 M shares +12%
Common Stock, Shares, Outstanding 47.5 M shares +11.9%
Entity Public Float 85.6 M USD -22.6%
Common Stock, Value, Issued 5 K USD 0%
Weighted Average Number of Shares Outstanding, Basic 50.6 M shares +19.2%
Weighted Average Number of Shares Outstanding, Diluted 50.6 M shares +19.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 2.72 M USD +283%
Research and Development Expense 73.9 M USD -8.05%
General and Administrative Expense 19.1 M USD -9.48%
Operating Income (Loss) -90.3 M USD +10.4%
Net Income (Loss) Attributable to Parent -85.1 M USD +13.3%
Earnings Per Share, Basic -1.93 USD/shares +16.8%
Earnings Per Share, Diluted -1.93 USD/shares +16.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 76 M USD +15.1%
Cash, Cash Equivalents, and Short-term Investments 115 M USD -15.4%
Assets, Current 131 M USD -17%
Property, Plant and Equipment, Net 12.8 M USD -24%
Operating Lease, Right-of-Use Asset 2.27 M USD -13.8%
Other Assets, Noncurrent 2.43 M USD -17.7%
Assets 146 M USD -17.6%
Accounts Payable, Current 2.15 M USD -58%
Employee-related Liabilities, Current 1.03 M USD -14.5%
Contract with Customer, Liability, Current 4.61 M USD
Liabilities, Current 14.3 M USD -10.5%
Operating Lease, Liability, Noncurrent 3.19 M USD -20.5%
Liabilities 17.5 M USD -12.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -14 K USD +95.9%
Retained Earnings (Accumulated Deficit) -325 M USD -35.5%
Stockholders' Equity Attributable to Parent 129 M USD -18.3%
Liabilities and Equity 146 M USD -17.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -16.2 M USD +38.9%
Net Cash Provided by (Used in) Financing Activities -184 K USD
Net Cash Provided by (Used in) Investing Activities -33.3 M USD -174%
Common Stock, Shares Authorized 300 M shares 0%
Common Stock, Shares, Issued 47.5 M shares +11.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -49.6 M USD -366%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 76 M USD +15.1%
Deferred Tax Assets, Valuation Allowance 76.4 M USD +38.8%
Deferred Tax Assets, Gross 77.9 M USD +37.4%
Operating Lease, Liability 4.2 M USD -14.3%
Depreciation 974 K USD -3.95%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -84.8 M USD +13.5%
Lessee, Operating Lease, Liability, to be Paid 5.09 M USD -17.6%
Property, Plant and Equipment, Gross 23.3 M USD -0.3%
Operating Lease, Liability, Current 821 K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.15 M USD +2.86%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.12 M USD +2.85%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 884 K USD -30.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.09 M USD -5.12%
Deferred Tax Assets, Operating Loss Carryforwards 31.4 M USD +26.2%
Preferred Stock, Shares Authorized 10 M shares 0%
Unrecognized Tax Benefits 3.26 M USD +36.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four 848 K USD -22.4%
Operating Lease, Payments 200 K USD
Additional Paid in Capital 454 M USD +14.1%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 1.55 M USD -6.67%
Share-based Payment Arrangement, Expense 7.73 M USD +16.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%